KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
about
Activation of NK cells by an endocytosed receptor for soluble HLA-G.Comparative genomics of natural killer cell receptor gene clusters.The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type ReceptorsSome basic aspects of HLA-G biologyKiller immunoglobulin-like receptors and tumor immunityThe Crystal Structure of CHIR-AB1: A Primordial Avian Classical Fc ReceptorNatural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologuesThe structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantationExpression of cDNAs in human Natural Killer cell lines by retroviral transduction.Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease.HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction.KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like LociUbiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signalingEpigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agentsA subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immatureDifferential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditions.MHC class I molecules and KIRs in human history, health and survival.KIR2DL4 (CD158d): An activation receptor for HLA-G.The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans.Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry.KIR and disease: a model system or system of models?Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.KIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NK cell subsets in SIV-infected Mamu-A*01-negative rhesus macaquesPlay it in E or G: utilization of HLA-E and -G in xenotransplantation.Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.Effects of simulated microgravity on primary human NK cells.DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors.Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
P2860
Q24813830-F1C0DC05-ACD5-4DF5-A1AE-F22E9001F610Q24816578-4D9A8ACA-0B1C-4178-B7FC-B38B13994C5FQ26742135-819C3D11-8D4E-453A-8EE3-8C1FEC185B84Q26752544-8D017FFB-BDCE-4531-A77E-EDEEAEFFCE83Q26852671-80280F41-054E-440C-A937-D4D4A10841C6Q27005792-44599DE6-D4E2-472D-B7C3-EEC59C01E4B2Q27651190-36B9D438-A060-47E0-9374-AF88FD80868AQ28755874-9C69DAB8-1B29-49C2-85D8-AB2AEF73ABEDQ30372604-19184EAB-22BD-4051-8207-80C7A66BD86DQ33365693-503C4F54-D648-4DD0-AC0C-2461CE259C65Q33557549-3B5A038C-D2DC-499A-8DDB-FF435D442135Q33595973-24EA2480-0ACC-4EFD-A245-8D72BF278889Q33672480-7B07F7D9-0573-4318-8A8C-F92E8F9657EEQ33789537-1DE35B0F-85E9-4661-8041-108685A98C4EQ34038019-95145FE0-1302-46E4-A50F-DDD3E81295C9Q34329051-4689D256-3013-463A-8D1E-C8A3CAD1ACA4Q34339809-36A4705B-D808-4ECB-9DEB-CFDDA374CF60Q34345310-F833A4BC-5FD0-4E55-9218-49D125020B17Q34596171-6D42ABB1-BE44-46F0-BCA0-D9E8D822AAB8Q34598133-D680C712-E5BE-4A57-8025-82A97226A17EQ34814738-53ECC7F9-E5DE-45C8-85D4-CBBF08D43EF7Q35620090-DFAC7EFC-7DA8-4E62-882A-AE5C980C4CF8Q35900982-228732B2-878D-4331-8D3D-1A4D1D143BEDQ35903235-B21B2701-1DE5-440C-B5D6-2E6D76222AEBQ36047157-AC26214C-0036-476A-8341-1AAFE9E07A87Q36174860-5DC28C8D-8883-44A1-B4BE-175164D576F4Q36334403-A8008D88-FBAD-4836-8F1F-EAC17D33DD57Q36505826-80E5A5E2-58FA-457C-B306-E35787AF9824Q36652201-09252359-8D33-488E-BC57-B3FF52160F26Q36700598-E4980550-0267-490E-9EB0-083D4F05DB62Q36759934-AA95A37E-0DFC-4ED0-B96D-2ADA52BCBEDFQ36816090-83426609-D663-43E0-8861-4E11B11AB636Q36830203-21F09F17-E776-4829-8FE2-171EBA43B469Q36986947-BA63D64F-3DD1-4C86-9365-73AACA8616BCQ36990211-954335A9-653C-48A8-915B-ACD270BC86B3Q37021151-A2511568-BBDB-4940-9312-757493CB45E3Q37090540-E88EEFF7-312A-4045-A1E6-3F045F5FA3C4Q37101973-593C99B4-E02F-4CB2-BC3D-10226238335EQ37128237-7C30CB7B-3679-42C2-BDED-7BF86FC6235AQ37128253-CDB87A5E-DA77-4680-9551-500234454C90
P2860
KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
KIR2DL4 is an IL-2-regulated N ...... s strong IFN-gamma production.
@en
type
label
KIR2DL4 is an IL-2-regulated N ...... s strong IFN-gamma production.
@en
prefLabel
KIR2DL4 is an IL-2-regulated N ...... s strong IFN-gamma production.
@en
P2093
P1476
KIR2DL4 is an IL-2-regulated N ...... s strong IFN-gamma production.
@en
P2093
Akiko Kikuchi-Maki
Kerry S Campbell
Sei-ichi Yusa
Tracey L Catina
P304
P356
10.4049/JIMMUNOL.171.7.3415
P407
P577
2003-10-01T00:00:00Z